Skip to content
Sunday, November 8, 2026
Stellar Central

Zimbabwe Declines ‘Unbalanced’ US Healthcare Assistance Deal Over Data Concerns

Medical aid image
The proposed US financial assistance was intended for programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has rejected a major US healthcare agreement worth $367m (£272m) spanning five years over Washington's demand for confidential information.

The decision came to light after a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "skewed".

A government spokesman later explained that the US was seeking genetic material for research and commercial purposes but was not willing to share the resulting advantages from future vaccines.

"We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for more talks to find a deal suitable to all parties so the country's critical HIV programme can be sustained.

Wider Background

Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a court halted a similar health funding agreement after legal challenges were filed about the security of citizens' medical information.

After returning to office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

USAID had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government deals to boost transparency and accountability.

As per statements, 16 African countries have so far signed these new health pacts, constituting more than $18.3bn in new funding.

Details of the Declined Agreement

The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership could have provided immense benefits for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy through US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".

"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any equivalent promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.

"In essence, our country would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be available to our people if a future health crisis emerge."

Sovereignty and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures already set up through the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage potential pandemics.

"This framework is intended to ensure that when a country provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."

These objections regarding the US deal "are not meant as opposition to America," Mangwana stressed.

"We are open to further discussions with our US partners on how subsequent collaboration could be arranged in a manner that honours the independence and interests of both nations."

Medical Community Response

Medical experts expressed it recognised the government's concerns, but recommended that negotiations should continue given that much of the nation's Aids initiatives relied on foreign aid.

"If specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it said.

The halted deal underscores the continuing tensions between receiving vital foreign assistance and protecting national sovereignty in an increasingly data-driven world.

KR
About the author

Karen Rogers

Award-winning astrophysicist and science communicator passionate about making space accessible to everyone.

Stellar Central

Type to search articles.